APC loss in breast cancer leads to doxorubicin resistance via STAT3 activationMonica K. VanKlompenberg(Mike and Josie Harper Cancer Research Institute), Jenifer R. Prosperi(Mike and Josie Harper Cancer Research Institute)OncotargetNovember 1, 201710.18632/oncotarget.22263Cited by 22SaveCiteExport RISWatch citationsRelated PapersAPC selectively mediates response to chemotherapeutic agents in breast cancer|BMC Cancer|2015|45